Document is current
Any future updates will be listed below
-
Authors
Gatoula, Panagiota
Diamantis, Dimitrios E.
Koulaouzidis, Anastasios
Carretero, Cristina
Chetcuti-Zammit, Stefania
Valdivia, Pablo Cortegoso
González-Suárez, Begoña
Mussetto, Alessandro
Plevris, John
Robertson, Alexander
Rosa, Bruno
Toth, Ervin
Iakovidis, Dimitris K.
-
Funding
Funding for this research was provided by:
Innovative Health Initiative (101172997, 101172997, 101172997, 101172997)
- License Information
-
More Information
Article History
Received: 9 March 2025
Accepted: 30 July 2025
First Online: 8 October 2025
Declarations
:
: A.K. reports that he is a co-director and shareholder of AJM Medicaps, and shareholder of iCERV Ltd; and has received consultancy fees (Jinshan Ltd. and DiagMed Healthcare Ltd.), travel support (Jinshan DiagMed Healthcare Ltd., Aquilant), research support (grant) from ESGE/Given Imaging Ltd. and (material) IntroMedic/SynMed, lecture honoraria (Jinshan, Medtronic). He participated in advisory board meetings for Tillots, ANKON, Dr Falk Pharma UK. The rest of the authors declare no competing interests.
